Christopher E. Banas, CEO
Arthur J. Tipton, PhD, President, joined Southern Research in 2004 to lead the formation of a new company based on Southern’s pharmaceutical formulations business. Brookwood Pharmaceuticals was launched in January 2005 with Dr. Tipton as President and CEO. He also directed the acquisition of Alkermes’ external polymer business which was completed in November 2004. The new company, Lakeshore Biomaterials, was established as a wholly-owned subsidiary of Brookwood. Immediately prior to joining Southern, Dr. Tipton served as Executive Vice President at Durect Corporation, a California-based, publicly traded drug delivery company. Dr. Tipton held a variety of positions in
During his career, his development efforts have led to the launch of four commercial products. He holds 22
Pual Castella, Ph.D., MBA; Chief Business Officer
Kevin W. Burton, Ph.D.; Chief Operating Officer has an extensive background in the research and development of a variety of products utilizing novel drug delivery systems with an emphasis on preclinical and early human proof of concept efforts. These products include those used for controlled and sustained delivery of therapeutic agents such as biodegradable microparticulates, organogels, hydrogels and polymer conjugates for the delivery of analgesics, antibiotics, opioids, opioid agonists, antineoplastics, steroids, and several peptides/proteins. Through his career at Purdue Pharma, DURECT, Nektar Therapeutics and now Brookwood Pharmaceuticals, Dr. Burton has led efforts from early discovery through late phase clinical trials holding key leadership positions in Technical and Scientific Writing, Program Management and Product Development departments. In these positions, Dr. Burton has provided oversight of the CMC aspects of Drug Substance and Drug Product development of parenteral and oral products including Pre-formulation and Formulation Development, Analytical Development, Scale up and Tech Transfer operations. Dr. Burton holds two patents and has contributed to more than 20 publications and presentations. Dr. Burton earned his degree in Pharmaceutical Sciences from the